|
|||||||||||||||||||
|
Combining complementarty, emerging, supra-disciplinary, technologies in nano-biotechnology NANORESISTANCE introduces an unprecedented integrated approach for the comprehensive management of failure to anti-cancer therapy and treatment monitoring. The inter-sectoral mobility between academia and industry will be a priority as a means to improve cooperation between the two sectors and to eliminate cultural and other mobility barriers in the context of the “Innovation Union” flagship initiative. The vibrant inter-sectoral mobility program of NANORESISTANCE will play a structuring role by allowing researchers to acquire key skills which are equally relevant to the public and private sectors. Important Dates
|
|
|||||||||||||||||
Funded by THE SEVENTH FRAMEWORK PROGRAMME THE PEOPLE PROGRAMME Marie Curie Actions - Industry-Academia Partnerships and Pathways |
|||||||||||||||||||
Home
|